Actuate Therapeutics (ACTU) Non Operating Interest Expenses (2023 - 2026)
Actuate Therapeutics' Non Operating Interest Expenses was $5,063 in Q2 2026, unchanged from $5,062 a year earlier.
Powered by 
Analysis
Actuate Therapeutics (ACTU) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Actuate Therapeutics' Non Operating Interest Expenses was $20,250 through Jun 30, 2026, up 8.3% year-over-year; for FY2025, it came in at $20,250, up 8.2% from FY2024.
- In earlier years, Non Operating Interest Expenses was $18,717 in FY2024 (-57.1%) and $43,641 in FY2023.
- Quarterly Non Operating Interest Expenses has moved between $3,489 (Q3 2024) and $5,076 (Q4 2024) over five years.
- Compared with a year earlier, Non Operating Interest Expenses was higher in two of the last seven quarters, with growth averaging 1.9%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2025 (growth of 45.1%); the worst was Q3 2024 (a decline of 31.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Actuate Therapeutics | 7.20 Mn | -35.44 Mn | - | 5,063.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,063.00 |
| Mar 31, 2026 | 5,062.00 |
| Dec 31, 2025 | 5,062.00 |
| Sep 30, 2025 | 5,063.00 |
| Jun 30, 2025 | 5,062.00 |
| Mar 31, 2025 | 5,063.00 |
| Dec 31, 2024 | 5,076.00 |
| Sep 30, 2024 | 3,489.00 |
| Jun 30, 2024 | 5,076.00 |
| Mar 31, 2024 | 5,076.00 |
| Dec 31, 2023 | 5,063.00 |
| Sep 30, 2023 | 5,062.00 |
| Jun 30, 2023 | 5,062.00 |
API Access
Actuate Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ACTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ACTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ACTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();